Expression of human telomerase reverse transcriptase and cyclin-D1 in offactory neuroblastoma

被引:5
作者
Wang, Sheng-Lan
Chen, Wan-Tzu
Li, Shau-Hsuan
Li, Sung-Wei
Yang, Sheau-Fang
Chai, Chee-Yin [1 ]
机构
[1] Kaoshing Med Univ, Dept Pathol, Kaohsiung, Taiwan
[2] Kaoshing Med Univ, Dept Radiat Oncol, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Oncol, Kaohsiung, Taiwan
关键词
olfactory neuroblastoma; human telomerase reverse transcriptase; cyclin-D1; prognosis;
D O I
10.1111/j.1600-0463.2007.apm_446.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Olfactory neuroblastoma is an uncommon neoplasm. Typically, these tumors are indolent with long-standing symptomatology, but the fact that the lesions are indeed malignant has been proven by the repeated demonstration that they can metastasize to distant organs. Suitable prognostic factors are lacking and therapeutic strategy still remains controversial. Expression of human telomerase reverse transcriptase (hTERT) is associated with most human malignancies and high levels have been correlated with poor prognosis in many cancers. In comparison, overexpression of cyclin-D1 occurs in several malignancies and has been associated with aggressive tumor behavior and poorer prognosis. In this study, we collected 16 olfactory neuroblastomas from the Kaohsiung Medical University Hospital. The aim was to investigate the value of immunoexpression of hTERT and cyclin-D1 in correlation with clinicopathologic features of olfactory neuroblastoma. Low and high cyclin-D1 expression was found in 6 and 10 cases, respectively. For hTERT, low and high protein expression was detected in 5 and 11 tumors, respectively. Cyclin-D1 expression was not correlated with selected parameters. However, high hTERT expression was significantly correlated with high Kadish stage. In conclusion, high hTERT expression can be considered a potential indicator of aggressive olfactory neuroblastoma.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 23 条
[11]   Creation of human tumour cells with defined genetic elements [J].
Hahn, WC ;
Counter, CM ;
Lundberg, AS ;
Beijersbergen, RL ;
Brooks, MW ;
Weinberg, RA .
NATURE, 1999, 400 (6743) :464-468
[12]   CYCLINS AND CANCER .2. CYCLIN-D AND CDK INHIBITORS COME OF AGE [J].
HUNTER, T ;
PINES, J .
CELL, 1994, 79 (04) :573-582
[13]  
KADISH S, 1976, CANCER, V37, P1571, DOI 10.1002/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO
[14]  
2-L
[15]   Cyclins D1, D3, E, and A in vulvar carcinoma patients [J].
Knopp, S ;
Bjorge, T ;
Nesland, JM ;
Tropé, C ;
Holm, R .
GYNECOLOGIC ONCOLOGY, 2005, 97 (03) :733-739
[16]   Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours [J].
Lantuejoul, S ;
Soria, JC ;
Moro-Sibilot, D ;
Morat, L ;
Veyrenc, S ;
Lorimier, P ;
Brichon, PY ;
Sabatier, L ;
Brambilla, C ;
Brambilla, E .
BRITISH JOURNAL OF CANCER, 2004, 90 (06) :1222-1229
[17]  
LEWIS JS, 1965, ARCHIV OTOLARYNGOL, V81, P169
[18]  
Maláska J, 2004, NEOPLASMA, V51, P90
[19]   Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy [J].
Martin, JA ;
DeYoung, BR ;
Gitelis, S ;
Weydert, JA ;
Klingelhutz, AJ ;
Kurriger, G ;
Buckwalter, JA .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2004, (426) :117-124
[20]   Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survival [J].
Rosenberg, E ;
Demopoulos, RI ;
Zeleniuch-Jacquotte, A ;
Yee, H ;
Sorich, J ;
Speyer, JL ;
Newcomb, EW .
HUMAN PATHOLOGY, 2001, 32 (08) :808-813